149 related articles for article (PubMed ID: 23173972)
1. Setting a colorimetric assay with MTT for assessment of trichomonicidal activity.
Sariego I; Monzote L; Rojas L
Curr Clin Pharmacol; 2014; 9(3):283-7. PubMed ID: 23173972
[TBL] [Abstract][Full Text] [Related]
2. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
[TBL] [Abstract][Full Text] [Related]
3. Biological variability in clinical isolates of Trichomonas vaginalis.
Gómez-Barrio A; Nogal-Ruiz JJ; Montero-Pereira D; Rodríguez-Gallego E; Romero-Fernandez E; Escario JA
Mem Inst Oswaldo Cruz; 2002 Sep; 97(6):893-6. PubMed ID: 12386717
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of trichomoniasis with tinidazole following desensitization in a patient allergic to metronidazole.
Biagi M; Slipke W; Smalley A; Tsaras G
Int J STD AIDS; 2021 Jan; 32(1):89-91. PubMed ID: 33121364
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
Schwebke JR; Barrientes FJ
Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
[TBL] [Abstract][Full Text] [Related]
6. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States.
Butler SE; Augostini P; Secor WE
Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315
[TBL] [Abstract][Full Text] [Related]
7. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
Narcisi EM; Secor WE
Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
[TBL] [Abstract][Full Text] [Related]
8. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
9. Antitrichomonal activity and docking analysis of thiazole derivatives as TvMP50 protease inhibitors.
Mena-Rejón G; Pérez-Navarro Y; Torres-Romero JC; Vázquez-Carrillo L; Carballo RM; Arreola R; Herrera-España Á; Arana-Argáez V; Quijano-Quiñones R; Fernández-Sánchez JM; Alvarez-Sánchez ME
Parasitol Res; 2021 Jan; 120(1):233-241. PubMed ID: 33073325
[TBL] [Abstract][Full Text] [Related]
10. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
Hager WD
Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
[TBL] [Abstract][Full Text] [Related]
11. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of various plants extracts on the growth of Trichomonas vaginalis.
Sharafi SM; Yousefi M; Yousefi HA; Asghari G; Darani HY
Infect Disord Drug Targets; 2013 Oct; 13(5):322-7. PubMed ID: 24712672
[TBL] [Abstract][Full Text] [Related]
13. 20S Proteasome as a Drug Target in Trichomonas vaginalis.
O'Donoghue AJ; Bibo-Verdugo B; Miyamoto Y; Wang SC; Yang JZ; Zuill DE; Matsuka S; Jiang Z; Almaliti J; Caffrey CR; Gerwick WH; Eckmann L
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451503
[TBL] [Abstract][Full Text] [Related]
14. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
Sobel JD; Nyirjesy P; Brown W
Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
[TBL] [Abstract][Full Text] [Related]
15. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
16. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis.
Küng E; Pietrzak J; Klaus C; Walochnik J
Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578
[TBL] [Abstract][Full Text] [Related]
18. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
[TBL] [Abstract][Full Text] [Related]
19. [Effect of tinidazole on T. vaginalis in vitro].
Savoia D; Martinetto P; Pugliese A
G Batteriol Virol Immunol Microbiol; 1972 Jan; 65(1):32-8. PubMed ID: 4134002
[No Abstract] [Full Text] [Related]
20. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
Mammen-Tobin A; Wilson JD
Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
